Helius Medical Technologies Stock Today
| HSDT Stock | USD 5.18 0.14 2.63% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Helius Medical is selling for under 5.18 as of the 18th of April 2024; that is -2.63% down since the beginning of the trading day. The stock's last reported lowest price was 5.15. Helius Medical has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Helius Medical Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of June 2022 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 27th of June 2014 | Category Healthcare | Classification Health Care |
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator , is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company has 887.29 K outstanding shares of which 72.19 K shares are currently shorted by private and institutional investors with about 0.18 trading days to cover. More on Helius Medical Technologies
Moving together with Helius Stock
| 0.67 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
Moving against Helius Stock
| 0.73 | ELMD | Electromed | PairCorr |
| 0.73 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
| 0.62 | BAX | Baxter International Sell-off Trend | PairCorr |
| 0.61 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.56 | CAH | Cardinal Health Financial Report 2nd of May 2024 | PairCorr |
| 0.48 | VMD | Viemed Healthcare Downward Rally | PairCorr |
| 0.42 | GCTK | GlucoTrack | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 9th of May 2024
Helius Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Helius Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Helius Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and President and Director | Philippe Deschamps | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Helius Medical report their recommendations after researching Helius Medical's financial statements, talking to executives and customers, or listening in on Helius Medical's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Helius Medical Techn. The Helius consensus assessment is calculated by taking the average forecast from all of the analysts covering Helius Medical. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of Helius Medical's profitability, liquidity, and operating efficiency, Helius Medical Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Helius Medical Techn is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helius Medical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Helius Medical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Helius Medical's financial leverage. It provides some insight into what part of Helius Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helius Medical Technologies (HSDT) is traded on NASDAQ Exchange in USA. It is located in 642 Newtown Yardley Road, Newtown, PA, United States, 18940 and employs 22 people. Helius Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Helius Medical's market, we take the total number of its shares issued and multiply it by Helius Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Helius Medical Techn conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 887.29 K outstanding shares of which 72.19 K shares are currently shorted by private and institutional investors with about 0.18 trading days to cover.
Helius Medical Technologies currently holds about 3.27 M in cash with (10.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
Check Helius Medical Probability Of Bankruptcy
Ownership AllocationRoughly 88.0 (percent) of Helius Medical outstanding shares are held by general public with 0.85 % owned by insiders and only 11.58 pct. by outside corporations.
Check Helius Ownership Details
Helius Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Helius Medical jumping above the current price in 90 days from now is about 91.28%. The Helius Medical Technologies probability density function shows the probability of Helius Medical stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.5014. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Helius Medical will likely underperform. Additionally, helius Medical Technologies has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Helius Medical to move above the current price in 90 days from now is about 91.28 (This Helius Medical Technologies probability density function shows the probability of Helius Stock to fall within a particular range of prices over 90 days) .
Helius Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Helius Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Helius Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Helius Medical's value.| Instituion | Recorded On | Shares | |
| Baader Bank Inc | 2023-09-30 | 0.0 | |
| Millennium Management Llc | 2023-09-30 | 0.0 | |
| Renaissance Technologies Corp | 2023-09-30 | 0.0 | |
| U.s. Bancorp | 2023-09-30 | 0.0 | |
| Geode Capital Management, Llc | 2023-09-30 | 0.0 | |
| Delta Investment Management, Llc | 2023-09-30 | 0.0 | |
| Cubist Systematic Strategies, Llc | 2023-09-30 | 0.0 | |
| Vanguard Group Inc | 2023-12-31 | 12.6 K | |
| Blackrock Inc | 2023-12-31 | 5.1 K | |
| Tower Research Capital Llc | 2023-12-31 | 1.4 K | |
| Ubs Group Ag | 2023-12-31 | 216 |
Helius Medical Historical Income Statement
Helius Medical Technologies Income Statement is one of the three primary financial statements used for reporting Helius's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Helius Medical Techn revenue and expense. Helius Medical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Helius Medical's Reconciled Depreciation is comparatively stable compared to the past year. View More FundamentalsHelius Stock Against Markets
Picking the right benchmark for Helius Medical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Helius Medical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Helius Medical is critical whether you are bullish or bearish towards Helius Medical Technologies at a given time. Please also check how Helius Medical's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Helius Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Helius Medical Corporate Directors
Helius Medical corporate directors refer to members of a Helius Medical board of directors. The board of directors generally takes responsibility for the Helius Medical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Helius Medical's board members must vote for the resolution. The Helius Medical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Savio Chiu | Independent Director | Profile | |
| Edward Straw | Independent Director | Profile | |
| Mitch Tyler | Director | Profile | |
| Huaizheng Peng | Director | Profile |
How to buy Helius Stock?
Before investing in Helius Medical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Helius Medical. To buy Helius Medical stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Helius Medical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Helius Medical stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Helius Medical Technologies stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Helius Medical Technologies stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Helius Medical Technologies, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Helius Stock please use our How to Invest in Helius Medical guide.
Already Invested in Helius Medical Technologies?
The danger of trading Helius Medical Technologies is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Helius Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Helius Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Helius Medical Techn is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Helius Medical Techn is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Helius Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Helius Medical Technologies Stock. Highlighted below are key reports to facilitate an investment decision about Helius Medical Technologies Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Helius Medical Techn information on this page should be used as a complementary analysis to other Helius Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Helius Stock analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Helius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Helius Medical. If investors know Helius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.56) | Revenue Per Share 1.059 | Quarterly Revenue Growth (0.53) | Return On Assets (0.61) | Return On Equity (1.69) |
The market value of Helius Medical Techn is measured differently than its book value, which is the value of Helius that is recorded on the company's balance sheet. Investors also form their own opinion of Helius Medical's value that differs from its market value or its book value, called intrinsic value, which is Helius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Helius Medical's market value can be influenced by many factors that don't directly affect Helius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Helius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.